We recently compiled a list of the 20 Best Biotech Stocks Under $20 to Buy Now. Taysha Gene Therapies, Inc. is placed sixth on our list of best biotech stocks under $20. TheFly reported on January 5 ...

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) is one of the best strong buy stocks to invest in under $5. Needham maintained a bullish outlook on Taysha Gene Therapies, Inc. (NASDAQ:TSHA) on January 6, ...

While we acknowledge the potential of TSHA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI ...

With strong 1-year returns and upside potential, Taysha Gene Therapies, Inc. (NASDAQ:TSHA) secures a spot on our list of the 12 best multibagger stocks to buy heading into 2026. As of December 17, ...

Taysha Gene Therapies Inc. (NASDAQ:TSHA) is a must-buy penny stock to buy now. On November 13, Piper Sandler analyst Biren Amin reaffirmed his Buy rating on Taysha Gene Therapies, assigning a $9 price ...

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) stock is trading lower on Friday, with a session volume of 4.695 million, as per data from Benzinga Pro. On Thursday, during after-hours trading, the company ...

The full rights to Taysha Gene Therapies Inc.’s lead gene therapy candidate are coming back to the company. In 2022, Astellas Pharma Inc. invested $50 million in Taysha for 15% of the company and the ...

Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Taysha Gene Therapies ( (TSHA)) has ...

Taysha Gene Therapies (NASDAQ:TSHA) jumped ~39% on Thursday after the U.S. FDA granted its Breakthrough Therapy designation for the company's lead candidate TSHA-102 as a treatment for Rett syndrome, ...

Taysha Gene Therapies, Inc. announced key updates on its TSHA-102 program, an investigational gene therapy for Rett syndrome, at the upcoming 2025 International Rett Syndrome Foundation Scientific ...